Growth Metrics

Edwards Lifesciences (EW) Gross Profit (2016 - 2026)

Edwards Lifesciences has reported Gross Profit over the past 17 years, most recently at $1.2 billion for Q4 2025.

  • For Q4 2025, Gross Profit rose 12.16% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $4.7 billion, up 9.52%, while the annual FY2025 figure was $4.7 billion, 9.52% up from the prior year.
  • Gross Profit for Q4 2025 was $1.2 billion at Edwards Lifesciences, up from $1.2 billion in the prior quarter.
  • Over five years, Gross Profit peaked at $1.2 billion in Q4 2025 and troughed at $528.7 million in Q4 2022.
  • A 5-year average of $1.0 billion and a median of $1.0 billion in 2022 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: crashed 48.18% in 2022 and later soared 92.06% in 2023.
  • Year by year, Gross Profit stood at $1.0 billion in 2021, then plummeted by 48.18% to $528.7 million in 2022, then skyrocketed by 92.06% to $1.0 billion in 2023, then grew by 7.7% to $1.1 billion in 2024, then increased by 12.16% to $1.2 billion in 2025.
  • Business Quant data shows Gross Profit for EW at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.